Clinical Trial Update: Clonazepam Effects on Brain Oscillations and Cognition in Schizophrenia [Phase 4]

View source ↗

Summary

The Phase 4 clinical trial examining clonazepam effects on brain oscillations and cognition in schizophrenia-related conditions has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia
• Schizophreniform Disorder

Drugs mentioned

• Clonazepam (Clonazepam)

Snippet

Sponsor: Palo Alto Veterans Institute for Research | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: WITHDRAWN